Increased Attributable Risk Related to a Functional μ-Opioid Receptor Gene Polymorphism in Association with Alcohol Dependence in Central Sweden

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neuropsychopharmacology

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.npp.1300598PMID 15525999
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genes associated with addiction

  2007cited by this paper
• Statistical Methods in Medical Research

  2006cited by this paper
• Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han.

  2004cited by this paper
• Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden

  2004cited by this paper
• Association of functional opioid receptor genotypes with alcohol dependence in Koreans.

  2004cited by this paper
• A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients

  2003cited by this paper
• Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations

  2003cited by this paper
• A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.

  2003cited by this paper
• Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ‐opioid receptor locus (OPRM1)

  2003cited by this paper
• Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European‐Americans

  2003cited by this paper
• Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis

  2002cited by this paper
• Hypothalamic-Pituitary-Adrenocortical (HPA) Axis Response and Biotransformation of Oral Naltrexone: Preliminary Examination of Relationship to Family History of Alcoholism

  2002cited by this paper
• A functional polymorphism within the μ-opioid receptor gene and risk for abuse of alcohol and other substances

  2002cited by this paper
• Pharmacotherapy of addictions

  2002cited by this paper
• Sequence variations in the mu‐opioid receptor gene (OPRM1) associated with human addiction to heroin

  2002cited by this paper
• The Mu-Opioid Receptor Gene Polymorphism (A118G) Alters HPA Axis Activation Induced by Opioid Receptor Blockade

  2002cited by this paper
• Ethanol consumption and reward are decreased in µ-opiate receptor knockout mice

  2001cited by this paper
• Confirmation that offspring from families with alcohol-dependent individuals have greater hypothalamic-pituitary-adrenal axis activation induced by naloxone compared with offspring without a family history of alcohol dependence.

  2001cited by this paper
• Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts

  2001cited by this paper
• Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence.

  2001cited by this paper
• Association analysis of polymorphisms in the mu opioid gene and heroin abuse in Chinese subjects

  2000cited by this paper
• μ-Opioid Receptor Knockout Mice Do Not Self-Administer Alcohol

  2000cited by this paper
• Quantitative Trait Locus Analysis

  2000cited by this paper
• Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence.

  2000cited by this paper
• Opioid receptor and peptide gene polymorphisms: potential implications for addictions.

  2000cited by this paper
• Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins.

  1999cited by this paper
• Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency.

  1999cited by this paper
• Genetics of two μ opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects

  1999influential reference
• Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

  1998influential reference
• Human μ‐Opioid Receptor Variation and Alcohol Dependence

  1998cited by this paper
• Family history of alcoholism and hypothalamic opioidergic activity.

  1998cited by this paper
• Human mu-opioid receptor variation and alcohol dependence.

  1998cited by this paper
• Drug dependence: stress and dysregulation of brain reward pathways.

  1998cited by this paper
• Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1).

  1998cited by this paper
• Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone-induced withdrawal.

  1997cited by this paper
• Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse

  1997influential reference
• Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

  1997cited by this paper
• μ opioid receptor gene variants: lack of association with alcohol dependence

  1997cited by this paper
• Temperance board registration for alcohol abuse in a national sample of Swedish male twins, born 1902 to 1949.

  1997cited by this paper
• Opioid receptors: Some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases

  1996cited by this paper
• Personality disorders according to DSM-III-R and thrombocyte monoamine oxidase activity in type 1 and type 2 alcoholics.

  1996cited by this paper
• Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism.

  1996influential reference
• Opiates and alcohol self-administration in animals.

  1995cited by this paper
• Naltrexone in the treatment of alcohol dependence.

  1994cited by this paper
• A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence.

  1994cited by this paper
• Naltrexone in the treatment of alcohol dependence.

  1992cited by this paper
• Effects of opiates, opioid antagonists and cocaine on the endogenous opioid system: clinical and laboratory studies.

  1992cited by this paper
• Plasma cortisol levels following ethanol in sons of alcoholics and controls.

  1987influential reference
• Inheritance of alcohol abuse. Cross-fostering analysis of adopted men.

  1981cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper
• Drinking habits in twins.

  1957cited by this paper

• Comparative mRNA profile analysis from NAc of adolescent male mice after binge-like alcohol exposure eliciting deficits in context fear extinction learning

  2025cites this paper
• Predicting postoperative chronic opioid use with fair machine learning models integrating multi-modal data sources: a demonstration of ethical machine learning in healthcare

  2025cites this paper
• Opioid Use Disorders: Prevention, Diagnosis, and Treatment Strategies to Mitigate Addiction Risks.

  2025cites this paper
• The interaction between candidate SNPs and social factors significantly influences the prevalence of alcohol use disorder in Chinese young male adults

  2025cites this paper
• Impact of OPRM1 (mu-opioid receptor gene) A112G polymorphism on dual oxycodone and cocaine self-administration behavior in a mouse model.

  2024cites this paper
• Inhibitory effects of the selective μ‐opioid receptor antagonist UD‐030 on methamphetamine‐induced conditioned place preference

  2024cites this paper
• Cholinergic mu-opioid receptor deletion alters reward preference and aversion-resistance.

  2024cites this paper
• Introduction: Approved treatments for alcohol use disorder by regulatory agencies.

  2024cites this paper
• Inhibitory Effects of a Novel μ-Opioid Receptor Nonpeptide Antagonist, UD-030, on Morphine-Induced Conditioned Place Preference

  2023cites this paper
• Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.

  2023cites this paper
• Lack of Association between a Functional Polymorphism in Dopamine and Opioid Receptor Genes with Alcoholism in South Indian Tamilian Population.

  2023cites this paper
• Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?

  2022cites this paper
• Pharmacogenetics of Addiction Therapy.

  2022cites this paper
• Landscape of Variability in Chemosensory Genes Associated With Dietary Preferences in Indian Population: Analysis of 1029 Indian Genomes

  2022cites this paper
• Hypermethylation of the OPRM1 and ALDH2 promoter regions in Chinese Han males with alcohol use disorder in Yunnan Province

  2021cites this paper
• Nicotine and Opioid Co-Dependence: Findings from Bench Research to Clinical Trials.

  2021cites this paper
• Journey from responsible alcohol drinking to alcoholism

  2021cites this paper
• The molecular neurobiology and neuropathology of opioid use disorder

  2021cites this paper
• Pharmacogenomics of ketamine: A systematic review.

  2021cites this paper
• FACTORS CONTRIBUTING TO THE ESCALATION OF ALCOHOL CONSUMPTION.

  2021cites this paper
• Neurotoxicity in Psychostimulant and Opiate Addiction

  2021cites this paper
• The Persistent Challenge of Developing Addiction Pharmacotherapies.

  2020cites this paper
• Genetic Polymorphism in Alcohol-dependent Genes: A Review

  2020cites this paper
• Genetic Vulnerability to Opioid Addiction.

  2020cites this paper
• Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol.

  2020cites this paper
• Associations among the opioid receptor gene (OPRM1) A118G polymorphism, psychiatric symptoms, and quantitative EEG in Korean males with gambling disorder: A pilot study

  2019cites this paper
• Current status of opioid addiction treatment and related preclinical research

  2019cites this paper
• Genetic association studies of alcohol dependence

  2019cites this paper
• Bi-directional Acceleration of Alcohol Use and Opioid Use Disorder

  2019cites this paper
• OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches

  2019cites this paper
• The role of OPRM1 polymorphism in the etiology of alcoholism.

  2019cites this paper
• Binge-Like Eating Is Not Influenced by the Murine Model of OPRM1 A118G Polymorphism

  2019cites this paper
• PGPM_A_198654 361..368

  2019cites this paper
• Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment

  2019cites this paper
• The association between the OPRM1 A118G polymorphism and addiction in a Turkish population

  2019cites this paper
• Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons

  2018cites this paper
• The Developmental Neuroepigenetics of Substance Abuse

  2018cites this paper
• Implication of OPRM1 A118G Polymorphism in Opioids Addicts in Pakistan: In vitro and In silico Analysis

  2018cites this paper
• Clinical Therapeutic Effect of Naloxone Combined with Hemodialysis on Acute Severe Alcoholism

  2018cites this paper
• Psychometric and behavioural examination of the validity of“food addiction” in the general population

  2018cites this paper
• Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems.

  2018cites this paper
• Opioid receptors: drivers to addiction?

  2018cites this paper
• OPRM1 A118G and serum β-endorphin interact with sex and digit ratio (2D:4D) to influence risk and course of alcohol dependence

  2017cites this paper
• A New Understanding of Mental Disorders: Computational Models for Dimensional Psychiatry

  2017cites this paper
• 12 Pharmacogenetics – A Treatment Strategy for Alcoholism

  2017cites this paper
• Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity.

  2017cites this paper
• Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.

  2017influential citation
• Convergent Balancing Selection on the Mu-Opioid Receptor in Primates

  2017cites this paper
• Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies

  2017cites this paper
• Medications for substance use disorders (SUD): emerging approaches

  2017cites this paper
• Comorbidity of Alcohol Use Disorder and Chronic Pain: Genetic Influences on Brain Reward and Stress Systems

  2017cites this paper
• Interaction Between the &mgr;‐Opioid Receptor Gene and the Number of Heavy‐Drinking Peers on Alcohol Use

  2017cites this paper
• Critical Review of Alcohol, Alcoholism and the Withdrawal Symptoms I. Mechanisms of Addiction and Withdrawal Syndrome

  2017cites this paper
• Antagonist Treatment for Opioid Dependence: Promise and Hurdles

  2017cites this paper
• Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury

  2017cites this paper
• Effect of single‐nucleotide polymorphisms in ADH1B,ADH4,ADH1C,OPRM1,DRD2,BDNF, and ALDH2 genes on alcohol dependence in a Caucasian population

  2017cites this paper
• Addiction: A multi-determined chronic disease

  2017cites this paper
• Lack of Association between Human µ-Opioid Receptor ( OPRM1 ) Gene Polymorphisms and Heroin Addiction in A Sample of Southeast Iranian Population

  2017cites this paper
• Addiction: A preclinical and clinical analysis

  2016cites this paper
• Pharmacogenomics in Psychiatric Practice.

  2016cites this paper
• From genetic studies to precision medicine in alcohol dependence

  2016cites this paper
• [μ-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample].

  2016cites this paper
• Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence.

  2016cites this paper
• Epigenetic Dysregulations in the Brain of Human Alcoholics : Analysis of Opioid Genes

  2016cites this paper
• Mouse Model of the OPRM1 (A118G) Polymorphism: Differential Heroin Self-Administration Behavior Compared with Wild-Type Mice

  2015cites this paper
• Serum soluble major histocompatibility complex class I-related chain A/B expression in patients with alcoholic liver disease in Hainan Li community.

  2015cites this paper
• Subjective response as a consideration in the pharmacogenetics of alcoholism treatment.

  2015cites this paper
• OPRM1 rs1799971 Genotype Predicts Drinking Behavior in Males, but Not Females

  2015cites this paper
• A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice.

  2015cites this paper
• A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.

  2015cites this paper
• Pharmacological Treatment of Substance Abuse Disorders

  2015cites this paper
• The pharmacogenetics of alcohol use disorder.

  2015cites this paper
• Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts

  2015cites this paper
• Affect dynamics : a focus on genes, stress, and an opportunity for change

  2015cites this paper
• The epidemiology and genetics of binge eating disorder (BED)

  2015cites this paper
• Recent Developments in Pharmacotherapy of Alcoholism

  2015cites this paper
• [Stabilization of remission in patients with opioid dependence with naltrexone implant: a pharmacogenetic approach].

  2015cites this paper
• Neurogenetics and Neurobiology of Dopamine in Anhedonia

  2014cites this paper
• Exploring variation of mu-opioid receptor gene and subjective opioid effects in healthy men

  2014cites this paper
• Nalmefene for the treatment of alcohol dependence: a current update.

  2014influential citation
• A Heroin Addiction Severity-Associated Intronic Single Nucleotide Polymorphism Modulates Alternative Pre-mRNA Splicing of the μ Opioid Receptor Gene OPRM1 via hnRNPH Interactions

  2014cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• Pharmacogenetics of addiction therapy.

  2014cites this paper
• Translational Investigations of Rewarding Substances Using the Curve-Shift Method of Intracranial Self-Stimulation in Mice

  2014cites this paper
• Alcohol: a stimulant activating brain stress responsive systems with persistent neuroadaptation.

  2014cites this paper
• Drinking to Dependence Risk Factors in Nonhuman Primates

  2014cites this paper
• A Psycho-Genetic Study of Hedonic Responsiveness in Relation to “Food Addiction”

  2014cites this paper
• Pharmacogenetics of OPRM1.

  2014cites this paper
• µ-Opioid Receptor Gene (OPRM1) Polymorphism A118G: Lack of Association in Finnish Populations with Alcohol Dependence or Alcohol Consumption

  2013cites this paper
• Low frequency genetic variants in the mu-opioid receptor ( OPRM 1 ) affect risk for addiction to heroin and cocaine

  2013cites this paper
• Molecular Adaptations in the Endogenous Opioid System in Human and Rodent Brain

  2013cites this paper
• Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents.

  2013cites this paper
• Biopsychological investigation of hedonic processes in individuals susceptible to overeating : role of liking and wanting in trait binge eating

  2013cites this paper
• On the Role of Genetic Testing for Personalized Drug Overdose Management

  2013cites this paper
• RGS17: an emerging therapeutic target for lung and prostate cancers.

  2013cites this paper
• The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction

  2013cites this paper
• Pharmacogenetics of Opioid and Alcohol Addiction

  2013cites this paper
• Mu Opioids and Their Receptors: Evolution of a Concept

  2013influential citation
• Neurogenetics and nutrigenomics of reward deficiency syndrome (RDS): Stratification of addiction risk and mesolimbic nutrigenomic manipulation of hypodopaminergic function

  2013cites this paper
• The μ-opioid receptor and treatment response to naltrexone.

  2013cites this paper